Review
doi: 10.1016/0305-7372(90)90074-p.
Long-term adjuvant tamoxifen therapy for breast cancer: the prelude to prevention
Affiliations
- PMID: 2224868
- DOI: 10.1016/0305-7372(90)90074-p
Item in Clipboard
Review
Long-term adjuvant tamoxifen therapy for breast cancer: the prelude to prevention
Cancer Treat Rev.
1990 Mar.
No abstract available
Similar articles
-
Chemosuppression of breast cancer with tamoxifen: laboratory evidence and future clinical investigations.Cancer Invest. 1988;6(5):589-95. doi: 10.3109/07357908809082124. Cancer Invest. 1988. PMID: 3063338 Review. No abstract available.
-
Tamoxifen: toxicities and drug resistance during the treatment and prevention of breast cancer.Annu Rev Pharmacol Toxicol. 1995;35:195-211. doi: 10.1146/annurev.pa.35.040195.001211. Annu Rev Pharmacol Toxicol. 1995. PMID: 7598491 Review.
-
Tamoxifen for the prevention of breast cancer: yes.Important Adv Oncol. 1995:187-200. Important Adv Oncol. 1995. PMID: 7672805 Review. No abstract available.
-
Antiestrogens as chemopreventive agents in breast cancer: promise and issues in evaluation.Prev Med. 1989 Sep;18(5):661-71. doi: 10.1016/0091-7435(89)90037-6. Prev Med. 1989. PMID: 2694160 Review.
-
How long should adjuvant tamoxifen be continued?Oncology (Williston Park). 1994 Oct;8(10):25-33; discussion 33, 37-8. Oncology (Williston Park). 1994. PMID: 7803214 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
